Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya VanPatten

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|September 27, 2016
The challenges of modulating the 'rest and digest' system: acetylcholine receptors as drug targetsSonya VanPatten, Yousef Al-Abed
Journal of Medicinal Chemistry|December 22, 2017
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug TargetSonya VanPatten, Yousef Al-Abed
Future Medicinal Chemistry|March 25, 2011
MIF as a disease target: ISO-1 as a proof-of-concept therapeuticYousef Al-Abed, Sonya VanPatten
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formationShan Sun, Mingzhu He, Sonya VanPatten, et al.
Molecular Medicine (Cambridge, Mass.)|November 10, 2020
SARS-CoV-2 and interferon blockadeBetty Diamond, Bruce T Volpe, Sonya VanPatten, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
The Biochemical Journal|February 27, 2004
Intracerebroventricular leptin regulates hepatic cholesterol metabolismSonya Vanpatten, George B Karkanias, Luciano Rossetti, et al.
Journal of Molecular Graphics & Modelling|April 23, 2013
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitorsMahmoud A Al-Sha'er, Sonya VanPatten, Yousef Al-Abed, et al.
Trends in Immunology|April 10, 2019
Rediscovering MIF: New Tricks for an Old CytokineJames Harris, Sonya VanPatten, Nadia S Deen, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodiesMingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|September 27, 2016
The challenges of modulating the 'rest and digest' system: acetylcholine receptors as drug targetsSonya VanPatten, Yousef Al-Abed
Journal of Medicinal Chemistry|December 22, 2017
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug TargetSonya VanPatten, Yousef Al-Abed
Future Medicinal Chemistry|March 25, 2011
MIF as a disease target: ISO-1 as a proof-of-concept therapeuticYousef Al-Abed, Sonya VanPatten
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formationShan Sun, Mingzhu He, Sonya VanPatten, et al.
Molecular Medicine (Cambridge, Mass.)|November 10, 2020
SARS-CoV-2 and interferon blockadeBetty Diamond, Bruce T Volpe, Sonya VanPatten, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
The Biochemical Journal|February 27, 2004
Intracerebroventricular leptin regulates hepatic cholesterol metabolismSonya Vanpatten, George B Karkanias, Luciano Rossetti, et al.
Journal of Molecular Graphics & Modelling|April 23, 2013
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitorsMahmoud A Al-Sha'er, Sonya VanPatten, Yousef Al-Abed, et al.
Trends in Immunology|April 10, 2019
Rediscovering MIF: New Tricks for an Old CytokineJames Harris, Sonya VanPatten, Nadia S Deen, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodiesMingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Pageof 2